The forecast for antacid medicine sales in Italy from 2024 to 2028 indicates a steady increase in per capita spending, rising from $1.3 to $2.1 in PPP terms. Year-on-year variations average around 14.3%, demonstrating consistent growth. The compound annual growth rate (CAGR) over this period is approximately 12.4%, highlighting a robust upward trajectory in the market.
Future trends to monitor include:
- Increased prevalence of digestive disorders, potentially driving demand.
- Innovation in product formulations, attracting new consumers.
- Regulatory changes impacting product availability and pricing.
- Consumer preferences shifting towards natural and organic remedies.
